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ABSTRACT: A stereoselective intermolecular Diels−Alder cycloaddition of an intermediate pyrazinone with both achiral and
chiral acrylate-derived dienophiles provides rapid access to the bicyclo[2.2.2]diazaoctane core shared among several prenylated
indole alkaloids. The product derived from cycloaddition with 2-nitroacrylate required an additional five to six synthetic
operations to intercept established precursors to premalbrancheamide and brevianamide B. The chemistry detailed in this
manuscript constitutes a formal total synthesis (12 steps each) of these [2.2.2]diazabicyclic natural products from proline methyl
ester.
■ INTRODUCTION
Isolated by Birch and Wright in 1969, the brevianamides were
the first metabolites discovered that possess the bicyclo[2.2.2]-
diazaoctane architecture.1 The [2.2.2]diazabicyclic alkaloid
family has since grown and now numbers nearly 100 distinct
fungal-derived prenylated indole natural products.2 Intriguing
biological activity is found across the family, and the alkaloids
exhibit antitumor, antihelmintic, insecticidal, and selective
phosphodiesterase (PDE1) inhibition and neuroprotective
properties.2,3 As a result, the [2.2.2]diazabicyclic alkaloids are
lead compounds in the treatment of several diseases and cancer.
Within the [2.2.2]diazabicyclic alkaloid family, metabolites
can possess either the syn or anti stereochemical configuration
at C19 (brevianamide numbering).4 Continued isolation efforts
have revealed enantiomeric5 and epimeric6 metabolites from
different fungal organisms (e.g., (+)-, (−)-stephacidin A, and 6-
epi-stephacidin A, Figure 1), a discovery that only increases the
allure of these alkaloids.
Because of potent and diverse bioactivities as well as
appealing molecular structure, the entire alkaloid group has
attracted the attention of the synthetic community. Efforts
directed to the synthesis of various congeners have revealed
several methods for the construction of the [2.2.2]diazabicyclic
core: (1) SN2′ cyclization, (2) biomimetic intramolecular
Diels−Alder cycloaddition (IMDA), (3) N-acyliminium-
initiated cyclization, (4) oxidative enolate coupling, (5) radical
cyclization, and (6) Dieckmann condensation with an
isocyanate component.7,8
The epimeric [2.2.2]diazabicycles 1 and 2 are the most
simple structures that contain all rings apparent within these
natural products. The syn-configured 1 can be converted to
premalbrancheamide, the biogenic precursor to more highly
halogenated compounds (e.g., malbrancheamide A and B).9
The anti-configured 2 is not a natural product but has served as
the penultimate intermediate in several syntheses of breviana-
mide B (3).10,8a The synthesis of compounds 1 or 2 have been
a proving ground for methods to construct the [2.2.2]-
diazabicyclic ring system, and the chemistry revealed in these
studies is often applied to more elaborate targets within the
natural product family.
The development of the biomimetic IMDA cycloaddition by
Williams has resulted in the total synthesis of several
[2.2.2]diazabicyclic alkaloids and led to important insights
into the biogenesis of these alkaloids.11 As an example of this
chemistry, diketopiperazine 4 can be isomerized to the reactive
pyrazinone intermediate 7, which undergoes cycloaddition to
give the diastereomers 5 and 6 (dr 2:1, Figure 2, entry 1).
Because the pyrazinone Diels−Alder precursor 7 is achiral, the
observed cycloadducts are racemic. Production of asymmetric
[2.2.2]diazabicyclic alkaloids via the IMDA has been realized
using a chiral aminal auxiliary precursor 88d (e.g., entry 3) as
well as two other nonracemic substrates.11a,12 Additionally,
Johnston and co-workers recently extended the IMDA
chemistry using a hydrogen bonding catalyst to modulate the
diastereo- and enantioselectivity of the reaction (entry 2).13 In
this way, syn-fused 5 can be produced in up to 4:1 dr and up to
44% ee depending on the catalyst used. In many ways, this
represents a normal evolution of reaction development, where
an initial reaction is rendered diastereoselective first with
auxiliaries and later made to be a catalytic enantioselective
process.
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■ RESULTS AND DISCUSSION
This manuscript describes our efforts toward 1 and 2 that focus
on an intermolecular Diels−Alder cycloaddition for the
construction of the [2.2.2]diazabicyclic system.
The Diels−Alder reaction is naturally efficient (forming two
bonds in concerted fashion), and the intermolecular variant is
intrinsically convergent. We believed that a strategy based on
intermolecular cycloaddition might offer improvements in
efficiency over several known routes and potentially permit
selective formation of either diastereomer 1 or 2 based on
modulation of the reaction conditions. Most importantly, the
fundamentals of the pyrazinone intermolecular Diels−Alder
cycloaddition are not fully understood, and we viewed a
synthesis of 1 and 2 as an instructive target to advance this
chemistry in more detail.
We previously established that pyrazinone Diels−Alder
precursors can be prepared in a single step by a domino
aldol condensation/alkene isomerization sequence.14 Accord-
ingly, our proposed synthesis toward 1 and 2 planned to engage
the requisite pyrazinone 10 prepared in this manner with a
suitable acrylate-derived dienophile to afford cycloadduct 3
(Scheme 1). Subsequent addition of an organometallic reagent
(e.g., MeMgBr) to the ester to afford an intermediate tertiary
alcohol would then permit Friedel−Crafts cyclization to
produce the quaternary carbon and complete the ring system.
Because both 1 and 2 are known, we anticipated that
verification of stereochemical outcome from the intermolecular
cycloaddition could be quickly determined by comparing to
published spectroscopic data or authentic standards.
Although this synthesis plan appeared concise, there were
significant regiochemical and stereochemical ambiguities with
regard to the intermolecular cycloaddition as well as
fundamental questions regarding reactivity. We predicted that
Figure 1. [2.2.2]Diazabicyclic natural products with syn and anti fusion.
Figure 2. Intramolecular Diels−Alder approaches to the formation of [2.2.2]diazabicyclic structures.
Scheme 1. Retrosynthesis Featuring an Intermolecular [4 +
2] Reaction
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a modest preference for the endo cycloadduct might be
enforced (leading to the anti-bicyclo fusion).
In order to evaluate the intermolecular cycloaddition,
pyrazinone 14 was prepared in one reaction vessel starting
from the proline-derived diketopiperazine (DKP) 12 (Scheme
2).15 The reaction sequence is initiated by enolization
(LiHMDS, 1.1 equiv) followed by aldol addition to the indole
carboxaldehyde. The intermediate β-alkoxy adduct was acylated
(Ac2O, 1.1 equiv) and treated with base (DBU, 1.4 equiv) in
order to effect elimination to the exocyclic diene in 13 and
subsequent isomerization to the DKP azadiene 14. Based on
experimental evidence, the exocyclic diene in 13 is short-lived
and isomerizes rapidly to the endocyclic azadiene 14, the
apparent thermodynamic alkene isomer and only identified
product from the reaction.
Although isolable, azadiene 14 proved somewhat difficult to
manipulate. The pyrazinone decomposed on exposure to silica
gel and was reactive with air, undergoing decomposition within
hours at room temperature.16 Nonetheless, we became
experienced at handling 14 as the unpurified product mixture
(obtained in 94% yield from the β-acetoxyaldol adduct, 90−
95% pure by 1H NMR) or as a homogeneous material obtained
by recrystallization, albeit in diminished yield (42%). In
practice, we also found it convenient to isolate and purify the
intermediate β-acetoxy adduct and advance material through
the elimination and isomerization to form 14 as needed.
We first attempted Diels−Alder cycloaddition of 14 with
ethyl acrylate and observed three products in a 3:1:1 ratio.17
The major product 15 was obtained in 48% isolated yield and
corresponds to cycloaddition from the endo transition state.
Due to the inconvenience of handling metastable pyrazinone
14, we also attempted a “one pot” reaction in order to
circumvent isolation of the reactive intermediate. Addition of
ethyl acrylate to the reaction vessel following completion of the
aldol condensation and alkene isomerization sequence
produced a low yield (15%) of desired cycloadduct 15. The
observed major product 16 (50% yield) was the result of
Michael addition. Formation of the Michael adduct could be
almost completely avoided with addition of a stoichiometric
amount of acetic acid (in order to buffer the basicity of residual
Scheme 2. Intermolecular Diels−Alder Cycloaddition with Acrylate Dienophiles
Scheme 3. Cycloaddition with Nitroacrylate and Formal Synthesis of Brevianamide B and Premalbrancheamide
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DBU) prior to addition of acrylate. In this way, the desired
major cycloadduct 15 was obtained in a commensurate amount
(40% isolated yield) and identical stereoselection (3:1:1) as
compared to the two-step sequence. Overall, this intermolec-
ular Diels−Alder reaction sequence required five to six steps
from commercially available proline methyl ester to create the
[2.2.2]diazabicyclic structure; however, the dominant product
possessed the undesired regiochemistry and would not permit
synthesis of 2 in a straightforward manner.
In the course of preparing suitable acrylate precursors, we
observed that the acrylamide derivative of Oppolzer’s sultam
was more selective in engaging pyrazinone substrate 14 and
could effectively introduce asymmetry to and improve
diastereoselection in the cycloaddition.18 The thermal cyclo-
addition of 14 with acryloyl camphor sultam afforded
cycloadduct 17 in 62% yield as an apparent single diastereomer
(>19:1) as determined by 1H NMR on the unpurified reaction
product mixture (Scheme 2, blue highlight).19 The acyl sultam
in 17 could be converted with lithio benzyl alcohol into the
corresponding ester 18.20
In order to obtain the desired regiochemistry whereby the
carboxyl moiety is positioned proximal to the indole nucleus,
we attempted cycloaddition with methyl 2-nitroacrylate (19), a
dienophile substrate that can be effective in reversing
cycloaddition regioselectivity.21 In the event, nitroacrylate 19
was more reactive than ethyl acrylate and cycloaddition with
pyrazinone 14 was achieved near ambient temperatures. Two
regioisomeric cycloadducts 20 and 21 (ratio 1:4) were
produced in 84% combined yield (Scheme 3). Both cyclo-
adducts arise from orientation of the nitro function in the endo
transition state. The dominant cycloadduct 21 possessed the
desired regiochemistry and we turned our attention to the three
remaining tasks to assemble the complete ring system relevant
to the [2.2.2]diazabicyclic alkaloid family: (1) removal of the
nitro group, (2) methylation of the ester (MeMgBr), and (3)
Friedel−Crafts cyclization.
Direct radical reduction of the secondary nitro group in 21
was attempted (Bu3SnH, AIBN, PhMe, 110 °C), although only
the product resulting from elimination (23) was observed.
Performing the reduction at lower temperatures (70−80 °C)
afforded mostly elimination product 23 but also a limited
quantity (ca. 10% yield) of 25, thereby validating the
stereochemistry of the cycloaddition. Due to the strong
propensity for elimination, we found it operationally most
convenient to expose the 1:4 mixture of cycloadducts 20 and
21 to DBU, which promoted elimination to the two isomeric
unsaturated ester products. The major isomer 23 was easily
separated by chromatography from the regioisomeric product
22. Hydrogenation of the unsaturation in 23 gave a nearly equal
mixture of syn- and anti-fused products 24 and 25.
Both diastereomers 24 and 25 were advanced in a short
number of operations to intercept known compounds. Product
24 was converted to anti-fused 2, a well-established
intermediate toward brevianamide B.22 Toward this end, the
ester in 24 was consumed with excess MeMgBr to afford the
derived tertiary alcohol. Acidic hydrolysis23 of the lactim ether
functionality to give the lactam 26 was required prior to
Friedel−Crafts cyclization of the indole on the derived tertiary
carbocation. Intermediate 27, which features the tertiary
alcohol and lactam structures, cleanly underwent indole BOC
deprotection and cyclization to give the desired annulated
product 2 in 83% yield. The spectral data for product 2 thus
obtained was identical to all properties of an authentic sample
provided by Williams.
The analogous lactim hydrolysis on syn-fused intermediate
25 intercepted the known lactam 28, an intermediate produced
by Baran and co-workers in the course of their synthesis of 1
and more complex natural products.24
The synthesis of 2 and 28 constitute 12-step formal total
syntheses of both brevianamide B (3) and premalbranchea-
mide, representative anti- and syn-fused [2.2.2]diazabicyclic
alkaloid natural products. The synthetic strategy based on
intermolecular pyrazinone cycloaddition is convergent and
provides a direct entry to the [2.2.2]diazabicyclic feature (four
to five steps from proline methyl ester). Further insight into the
pyrazinone Diels−Alder was obtained in this study. In
particular, we demonstrated that the use of a 2-nitroacrylate
dienophile was required to obtain the desired regiochemistry.
Extension of this intermolecular cycloaddition with chiral
nitroacrylate derivatives25 could enable construction of
structures in either enantiomeric series. Additionally, we plan
to continue to explore other possible stereoselective operations,
such as directed or diastereoselective reduction, in the
application of this synthetic strategy to more intricate and
bioactive natural products in the [2.2.2]diazabicyclic prenylated
indole alkaloid family.
■ EXPERIMENTAL SECTION
General Information. All reactions were carried out under an
atmosphere of nitrogen in flame-dried or oven-dried glassware with
magnetic stirring unless otherwise indicated. Acetonitrile, THF,
toluene, and Et2O were degassed with argon and purified by passage
through a column of molecular sieves and a bed of activated alumina.
Dichloromethane was distilled from CaH2 prior of use. All reagents
were used as received unless otherwise noted. Flash column
chromatography was performed using silica gel (230−400 mesh).
Analytical thin-layer chromatography was performed on 60 Å glass
plates. Visualization was accomplished with UV light, anisaldehyde,
ceric ammonium molybdate (CAM), potassium permanganate, or
ninhydrin, followed by heating. 1H NMR spectra were recorded on a
400 MHz spectrometer and are reported in ppm using solvent as an
internal standard (CDCl3 at 7.26 ppm) or tetramethylsilane (0.00
ppm). Proton-decoupled 13C NMR spectra were recorded on a 400
MHz spectrometer and are reported in ppm using solvent as an
internal standard (CDCl3 at 77.0 ppm). All compounds were judged to
be homogeneous (>95% purity) by 1H and 13C NMR spectroscopy
unless otherwise noted as mixtures. Mass spectra data analysis was
obtained through positive electrospray ionization (ICR-MS w/NaCl).
tert-Butyl 3-((1-Methoxy-4-oxo-4,6,7,8-tetrahydropyrrolo-
[1,2-a]pyrazin-3-yl)methyl)-1H-indole-1-carboxylate (14). To
diketopiperazine (DKP) 128d (384 mg, 2.29 mmol) in PhMe (8
mL) and DMF (8 mL) at −78 °C was added LiHMDS (2.50 mL, 1.0
M in THF, 1.1 equiv) dropwise over 5 min by syringe. After the
mixture was stirred for 15 min at −78 °C, N-Boc-indole
carboxaldehyde (0.56 g, 1.0 equiv) in PhMe (8 mL) was added, and
the reaction was stirred for an additional 15 min at −78 °C. Ac2O
(0.28 mL, 3.0 mmol, 1.3 equiv) was added, and the cooling bath was
removed. The reaction mixture was stirred at rt for 3 h, at which time
DBU (0.48 mL, 3.2 mmol, 1.4 equiv) was added and the reaction was
stirred at rt for 18 h. The reaction was then diluted with 0.1 M HCl
(50 mL) and extracted with EtOAc (3 × 20 mL). The combined
organic layers were washed with satd aqueous NaHCO3 and brine,
dried (Na2SO4), and concentrated in vacuo. The resulting product
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(0.91 g, quant mass recovery, ca. 95% pure by 1H NMR) was
recrystallized (hexanes/EtOAc) to afford analytically pure 14 (0.38 g,
42% yield) as a yellow amorphous solid. Pyrazinone 14 can be stored
(in the dark) for several weeks under inert gas at −15 °C without
appreciable degradation: TLC (100% EtOAc) Rf 0.40 (UV/CAM); IR
(film) 2976, 2939, 1730, 1653, 1584, 1579, 1452, 1369, 1349, 1256,
1157, 1080, 1046, 1016, 855, 750 cm−1; 1H NMR (400 MHz, CDCl3)
δ 8.10 (s, 1H), 7.75 (d, J = 7.3 Hz, 1H), 7.61 (s, 1H), 7.29−7.19 (m,
2H), 4.19 (s, 2H), 4.14 (t, J = 7.0 Hz, 2H), 3.82 (s, 3H), 3.04 (t, J =
7.4 Hz, 2H), 2.21 (q, J = 7.4 Hz, 2H), 1.65 (s, 9H); 13C NMR (100
MHz, CDCl3) δ 154.0, 149.8, 149.6, 142.5, 135.5, 130.8, 125.4, 124.2,
124.1, 122.2, 120.0, 116.7, 115.0, 83.3, 54.8, 49.5, 28.4, 28.2, 28.1, 21.6;
exact mass calcd for C22H25N3O4 [M + Na]
+ 418.1743, found
418.1735.
tert-Butyl 3-(Acetoxy((8aS)-1-methoxy-4-oxo-3,4,6,7,8,8a-
hexahydropyrrolo[1,2-a]pyrazin-3-yl)methyl)-1H-indole-1-car-
boxylate. To DKP 12 (2.16 g, 12.9 mmol) in THF (71 mL) at −78
°C was added LiHMDS (14.1 mL, 1 M in THF) dropwise and the
mixture stirred for 30 min at −78 °C. N-Boc-indole carboxaldehyde
(3.31 g, 13.5 mmol) was added as a solution in THF (10 mL)
dropwise over 5 min, and the reaction was stirred for an additional 30
min at −78 °C. Ac2O (1.82 mL, 19.3 mmol) and pyridine (1.55 mL,
19.3 mmol) were each added dropwise over 5 min, and the cold bath
was removed. The reaction was allowed to warm to rt and stir for 16 h
and was then diluted with HCl (20 mL, 0.1 M) and extracted with
EtOAc (3 × 30 mL). The combined organic extracts were washed with
satd aqueous NaHCO3 (50 mL), saturated NaCl (50 mL), dried
(Na2SO4), filtered, and concentrated in vacuo to afford the β-acetoxy
product as a mixture of four diastereomers. The resulting residue was
purified by flash column chromatography on silica gel (gradient
elution: 30% → 100% EtOAc in hexanes). The four diastereomers
were collected together to afford a pale yellow amorphous solid (5.32
g, 91% yield): mp 58.0−59.1 °C; TLC (80% EtOAc in hexanes) Rf
0.25−0.35 (UV/CAM); IR (film) 2980, 2945, 2886, 1732, 1676, 1657,
1451, 1368, 1338, 1310, 1252, 1219, 1152, 1080, 1017, 947, 853, 839,
764, 747, 700, 631, 600, 592 cm−1; 1H NMR (400 MHz, CDCl3)
8.13−8.01 (m, 1H), 7.96−7.91 (m, 1H), 7.74−7.52 (m, 1H), 7.32−
7.18 (m, 2H), 6.89−6.41 (m, 1H), 4.77−4.28 (m, 1H), 4.05−3.94 (m,
1H), 3.79−3.72 (m, 3H), 3.70−3.63 (m, 1H), 3.50−3.31 (m, 1H),
2.31−2.22 (m, 1H), 2.16−2.01 (m, 3H), 1.93−1.69 (m, 2H), 1.62−
1.29 (m, 1H), 1.66−1.64 (m, 9H); 13C NMR (100 MHz, CDCl3): δ
170.2, 169.8, 169.4, 165.9, 165.5, 165.2, 165.1, 163.4, 163.1, 162.5,
162.4, 149.6, 149.7, 149.5, 135.3, 135.1, 129.8, 129.5, 128.9, 128.6,
125.6, 125.4, 125.0, 124.7, 124.6, 124.4, 124.3, 124.1, 122.7, 122.6,
122.5, 122.3, 121.8, 120.8, 120.4, 120.0, 118.6, 116.9, 116.8, 116.7,
115.2, 115.1, 114.8, 84.1, 83.6, 83.6, 71.1, 71.0, 70.4, 66.0, 65.8, 63.7,
63.4, 56.9, 56.8, 56.6, 56.3, 53.8, 53.7, 53.6, 44.6, 44.4, 44.3, 44.2, 29.6,
29.4, 29.1, 28.7, 28.3, 28.2, 28.1, 22.6, 22.4, 21.9, 21.7, 21.3, 21.2, 21.1;
exact mass calcd for C24H29N3O6Na [M + Na]
+ 478.1949, found
478.1946.
tert-Butyl 3-((1-Methoxy-4-oxo-4,6,7,8-tetrahydropyrrolo-
[1,2-a]pyrazin-3-yl)methyl)-1H-indole-1-carboxylate (14). A
flame-dried flask was charged with β-acetoxy aldol addition product
(1.37 g, 3.00 mmol), wrapped in aluminum foil, flushed with N2 gas
for 10 min, and dissolved in PhMe (15 mL) and DMF (3 mL). To the
reaction flask was added DBU (0.89 mL, 6.00 mmol), and the reaction
was stirred for 16 h, diluted with HCl (20 mL, 0.2 M), and extracted
with EtOAc (3 × 30 mL). The combined organic extracts were washed
with satd aqueous NaHCO3 (50 mL) and saturated NaCl (50 mL),
dried (Na2SO4), filtered, and concentrated in vacuo to afford
pyrazinone 14 as a yellow amorphous solid (1.12 g, 94% yield).
Vide infra for spectral information.
Ethyl (6R*,8R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-8-carboxylate (15). A flame-dried
flask was charged with pyrazinone 14 (227 mg, 0.575 mmol) and
fitted with a reflux condenser. The starting material was dissolved in
DMF (3.8 mL, 0.15 M), and the reaction vessel was degassed
(evacuated and backfilled with N2 × 5). Ethyl acrylate (0.12 mL, 114
mg, 1.14 mmol) was added, and the reaction vessel was heated at 60
°C for 24 h, cooled to rt, and concentrated in vacuo to afford a brown
oil. Analysis of the unpurified reaction mixture reveals a 3:1:1 mixture
of diastereomers. Purification by flash column chromatography on
silica gel (gradient elution: 30% → 100% EtOAc in hexanes) afforded
product 15 (138 mg, 48% yield) as a colorless oil: TLC (60% EtOAc
in hexane) Rf 0.30 (CAM); IR (film) 2985, 2945, 2876, 1736, 1683,
1642, 1456, 1416, 1308, 1260, 1156, 1085, 1016, 852, 768, 745 cm−1;
1H NMR (400 MHz, CDCl3) 8.10 (br s, 1H), 7.78 (d, J = 7.5 Hz, 1H),
7.68 (s, 1H), 7.24 (m, 2H), 4.05 (m, 2H), 3.75 (s, 3H), 3.50−3.30 (m,
2H), 3.44 (d, J = 14.8 Hz, 1H), 3.34 (d, J = 14.8 Hz, 1H), 2.78 (dd, J =
9.8, 5.5 Hz, 1H), 2.61 (m, 1H), 2.05−1.85 (m, 4H), 1.80 (dd, J = 13.2,
5.5 Hz, 1H), 1.64 (s, 9H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 172.3, 163.0, 160.8, 149.5, 134.9, 132.1, 130.3, 129.0,
128.4, 128.2, 125.3, 124.7, 123.0, 118.9, 116.1, 155.5, 115.1, 104.8,
83.7, 65.6, 60.7, 54.3, 43.8, 35.0, 32.4, 29.0, 28.2, 28.1, 20.2, 14.0; exact
mass calcd for C27H33N3O6 [M + Na]
+ 518.2261, found 518.2259.
tert-Butyl (Z)-3-((8a-(3-Ethoxy-3-oxopropyl)-1-methoxy-4-
oxo-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-3(4H)-ylidene)-
methyl)-1H-indole-1-carboxylate (16). The reaction was executed
according to the conditions previously described for the preparation of
14. Prior to aqueous workup of 14 (0.38 mmol, assuming quantitative
formation), ethyl acrylate (0.080 mL, 0.76 mmol, 2 equiv) was added,
and the reaction was warmed to 60 °C and stirred for an additional 24
h. The reaction mixture was diluted with 0.2 M HCl (30 mL) and
extracted with EtOAc (3 × 20 mL). The combined organic layers were
washed with satd aqueous NaHCO3 and brine, dried (Na2SO4), and
concentrated in vacuo. The resulting residue was purified by flash
chromatography on silica gel (gradient elution: 40 → 100% EtOAc in
hexane) to afford 15 (28 mg, 15% yield) and 16 (94 mg, 50% yield) as
a yellow oil. Data for compound 16: TLC (60% EtOAc in hexane) Rf
0.50 (UV, CAM); IR (film) 2980, 2880, 1732, 1680, 1646, 1456, 1411,
1300, 1270, 1154, 1018, 740 cm−1; 1H NMR (400 MHz, CDCl3); 8.60
(s, 1H), 8.18 (d, J = 7.4 Hz, 1H), 7.84 (dd, J = 7.4, 1.6 Hz, 1H), 7.34
(m, 2H), 4.10−3.92 (m, 2H), 4.01 (s, 3H), 2.22−2.00 (m, 8H), 3.40
(m, 4H), 1.67 (s, 9H), 1.14 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 172.3, 162.9, 160.8, 149.5, 132.0, 130.2, 128.3, 124.6, 123.0,
118.8, 116.0, 115.4, 115.1, 83.6, 65.6, 60.7, 54.3, 43.8, 35.0, 32.3, 28.9,
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28.2, 28.0, 20.0, 14.0; exact mass calcd for C27H33N3O6 [M + Na]
+,
518.2261, found 518.2257.
The reaction was executed according to the conditions previously
described conditions used for the preparation of 14. Prior to aqueous
workup of 14 (0.1 mmol, assuming quantitative formation), AcOH (6
μL, 0.1 mmol, 1 equiv) and ethyl acrylate (20 μL, 0.2 mmol, 2 equiv)
were added, and the reaction was warmed to 60 °C and stirred for an
additional 24 h. The reaction mixture was diluted with 0.2 M HCl (10
mL) and extracted with EtOAc (3 × 10 mL). The combined organic
layers were washed with satd aqueous NaHCO3 and brine, dried
(Na2SO4), and concentrated in vacuo. The resulting residue was
purified by flash chromatography on silica gel (gradient elution: 40 →
100% EtOAc in hexane) to afford 15 (20 mg, 40% yield). Vide infra
for spectral information.
tert-Butyl 3-(((6R,8R,8aS)-8-((7aR)-8,8-Dimethyl-2,2-dioxido-
hexahydro-3H-3a,6-methanobenzo[c]isothiazole-1-carbonyl)-
9 -m e t h o x y - 5 - o x o - 2 , 3 , 7 , 8 - t e t r a h y d r o - 1H - 6 , 8 a -
(azenometheno)indolizin-6(5H)-yl)methyl)-1H-indole-1-car-
boxylate (17). To a flame-dried flask were added acryloyl
(+)-camphorsultam (135 mg, 0.51 mmol) and pyrazinone 14 (188
mg, 0.48 mmol). The flask was fitted with a condenser and flushed
with N2. The reactants were dissolved in DMF (3.2 mL, 0.15 M), and
the vessel was evacuated and backfilled with N2 (×5) before heating to
60 °C. After being heated for 24 h, the reaction mixture was cooled to
rt and concentrated in vacuo to afford a brown oil. Analysis of the
unpurified reaction mixture by 1H NMR reveals a single cycloadduct as
well as some unreacted sultam dienophile. Purification by flash column
chromatography on silica gel (gradient elution: 30% → 70% EtOAc in
hexanes) afforded cycloadduct 17 (260 mg, 62% yield) as a colorless
oil: TLC (80% EtOAc in hexane) Rf 0.3 (CAM); [α]D
25 = +59 (c 1.0,
CH2Cl2); IR (film) 3854, 3744, 3061, 2986, 2882, 2360, 2337, 1730
1683, 1648, 1635, 1452, 1363, 1351, 1308, 1298, 1268, 1258, 1218,
1164, 1135, 1083, 1015, 987, 768, 735, 667, 533 cm−1; 1H NMR (400
MHz, CDCl3) 8.1 (s, 1H), 7.77 (d, J = 1.14 Hz, 1H), 7.66 (s, 1H),
7.23 (m, 2H), 3.77 (s, 3H), 3.75 (m, 1H), 3.52−3.42 (m, 4H), 3.38 (d,
J = 13.7 Hz, 1H), 3.30 (d, J = 14.8 Hz, 1H), 2.47 (dd, J = 11.7, 6.6 Hz,
1H), 2.15−1.81 (m, 10H), 1.68 (dd, J = 13.3, 5.5 Hz, 1H), 1.66 (s,
9H), 1.30 (m, 2H), 1.15 (s, 3H), 0.96 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 172.2, 170.9, 169.5, 149.8, 135.1, 132.1, 125.5, 123.6, 121.9,
120.4, 116.5, 114.8, 83.1, 66.3, 66.2, 65.4, 54.5, 53.1, 49.0 48.2, 47.7,
44.6, 43.2, 38.5, 34.9, 32.9, 28.8, 28.2, 27.2, 26.3, 24.4, 20.9, 19.8; exact
mass calcd for C35H44N4O7S [M + Na]
+ 687.2823, found 687.2813.
Benzyl (6R,8R,8aS)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-8-carboxylate (18). To a flame-dried
reaction flask under N2 were added BnOH (13 μL, 0.12 mmol) and
THF (0.6 mL), the vessel was cooled to −78 °C, and a solution of n-
BuLi (3.0 M in pentane, 33 μL, 0.01 mmol) was added. In a separate
flask, sultam adduct 17 (20 mg, 0.03 mmol) was dissolved in THF
(0.25 mL), and the solution was transferred via cannula to the reaction
flask (which contained the LiOBn solution). After the cannula wire
was rinsed with an additional 0.15 mL of THF, the −78 °C cooling
bath was exchanged for an ice/water bath (0 °C). The reaction
mixture was stirred at 0 °C for 8 h, diluted with satd aq NH4Cl (15
mL), and extracted with EtOAc (3 × 10 mL). The combined organic
extracts were washed with satd aq NaHCO3 and brine, dried
(Na2SO4), and concentrated in vacuo. The resulting oil was purified
by flash column chromatography on silica gel (gradient elution: 30%
→ 70% EtOAc in hexanes) to afford the benzyl ester 18 as a light
yellow oil (13 mg, 75% yield): TLC (60% EtOAc in hexane) Rf 0.6
(CAM); [α]D
25 = +25 (c 0.3, CH2Cl2); IR (film) 2985, 2942, 2882,
2358, 2330, 1730, 1686, 1639, 1452, 1370, 1308, 1257, 1160, 1085,
1015, 912, 857, 746, 668, 664 cm−1; 1H NMR (400 MHz, CDCl3)
8.11 (s, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.66 (s, 1H), 7.34−7.28 (m,
4H), 7.24−7.18 (m, 3H) 5.06 (d, J = 12.1 Hz, 1H), 4.98 (d, J = 12.1
Hz, 1H), 3.65 (s, 3H), 3.50 (m, 1H), 3.45 (d, J = 14.8 Hz, 1H), 3.35
(m, 1H), 3.34 (d, J = 14.8 Hz, 1H), 2.84 (dd, J = 10.2, 5.5 Hz, 1H),
2.57 (dd, J = 13.3, 5.1 Hz, 1H), 2.10−1.85 (m, 4H), 1.84 (dd, J = 13.3,
5.5, 1H), 1.66 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.4, 171.4,
169.6, 135.3, 132.3, 128.8, 125.8, 124.1, 122.3, 120.7, 116.7, 115.1,
83.4, 67.2, 66.6, 65.9, 54.6, 49.3, 43.6, 34.2, 30.6, 29.1, 28.5, 28.4, 24.9,
13.8; exact mass calcd for C32H35N3O6 [M + Na]
+ 580.2418, found
580.2405.
Methyl (6S*,7S*,8S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-
indol-3-yl)methyl)-9-methoxy-7-nitro-5-oxo-2,3,5,6,7,8-hexa-
hydro-1H-6,8a-(azenometheno)indolizine-8-carboxylate (20)
and Methyl (6S*,7R*,8R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-
1H-indol-3-yl)methyl)-9-methoxy-8-nitro-5-oxo-2,3,5,6,7,8-
hexahydro-1H-6,8a-(azenometheno)indolizine-7-carboxylate
(21). A dry flask was charged with pyrazinone 14 (531 mg, 1.34
mmol) and flushed with N2 gas for 30 min and dissolved in toluene (7
mL). A separate flask was charged with nitroacrylate 19 (158 mg, 1.21
mmol) and flushed with N2 gas for 30 min and dissolved in toluene (2
mL). The reaction flask containing pyrazinone 14 was cooled to −10
°C (ice/salt bath). The nitroacrylate solution was dropwise to the
reaction vessel over 10 min. The reaction was allowed to stir and
slowly warm to rt overnight (16 h). The solution was concentrated in
vacuo to afford a brown oil, which contained the two regioisomeric
cycloadducts 20 and 21 in a 1:4 ratio (as judged by 1H NMR on the
unpurified reaction mixture). The resulting residue was purified by
flash column chromatography on silica gel (gradient elution: 10% →
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80% EtOAc in hexanes). A small amount of pure 21 (40 mg) was
obtained for analytical purposes and the bulk of the material was
obtained as a yellow oil that was comprised of a 1:4 mixture of 20 and
21 (593 mg, 84% yield): TLC (80% EtOAc in hexanes) Rf 0.30, 0.35
(CAM/UV). IR (film) 3052, 2980, 2950, 1733, 1704, 1641, 1608,
1559, 1477, 1452, 1410, 1370, 1309, 1219, 1197, 1158, 1086, 1016,
979, 937, 897, 857, 811, 768, 747, 703, 656 cm−1; 1H NMR (400
MHz, CDCl3): δ 8.13 (d, J = 5.9 Hz, 1H), 7.76 (d, J = 1.6, 1H), 7.74
(d, J = 7.8 Hz, 1H), 7.29 (dt, J = 8.2, 1.2 Hz, 1H) 7.21 (dt, J = 7.8, 0.8
Hz, 1H), 5.05 (d, J = 4.3 Hz, 1H), 3.77 (s, 3H) 3.76 (s, 3H), 3.62−
3.52 (m, 3H), 3.34 (d, J = 4.3 Hz, 1H), 3.30 (d, J = 15.7 Hz, 1H),
2.72−2.66 (m, 1H), 2.25−2.00 (m, 3H), 1.68 (s, 9H); 13C NMR (100
MHz, CDCl3): δ 169.6, 169.1, 168.7, 149.7, 135.1, 132.0, 125.5, 124.0,
121.9, 120.5, 115.3, 114.9, 88.9, 83.3, 68.6, 65.3, 55.4, 53.1, 51.0, 44.0,
28.2, 27.2, 26.8, 24.3; exact mass calcd for C26H30N4O8Na [M + Na]
+
549.1953, found 549.1956.
Methyl (6S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)methyl)-9-methoxy-5-oxo-2,3,5,6-tetrahydro-1H-6,8a-
(azenometheno)indolizine-8-carboxylate (22) and Methyl
(6S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-yl)methyl)-
9-methoxy-5-oxo-2,3,5,6-tetrahydro-1H-6,8a-(azeno-
metheno)indolizine-7-carboxylate (23). A flask was charged with
cycloadducts 20 and 21 (ratio 1:4, 588 mg, 1.12 mmol), flushed with
N2 gas, and dissolved in PhMe (18 mL). To the reaction vessel was
added DBU (277 μL, 1.86 mmol), and the reaction mixture was stirred
for 16 h at rt, diluted with HCl (0.1 M, 10 mL), and extracted with
EtOAc (3 × 15 mL). The combined organic portions were washed
with saturated NaHCO3 (20 mL) and saturated NaCl (20 mL), dried
(Na2SO4), filtered, and concentrated in vacuo to give the α,β-
unsaturated methyl ester regioisomers 22 and 23 in a 1:4 ratio as
judged by 1H NMR on the unpurified reaction mixture. The residue
was purified by flash column chromatography on silica gel (gradient
elution: 20% → 80% EtOAc in hexanes) to afford the minor
regioisomer 22 as a light yellow oil (62.1 mg, 12% yield) and 23 as a
pale yellow powder (376 mg, 70% yield). Spectroscopic data reported
for 22: TLC (40% EtOAc in hexanes) Rf 0.45 (CAM/UV); IR (film)
2890, 2884, 1721, 1688, 1634, 1607, 1451, 1369, 1339, 1327, 1308,
1267, 1256, 1244, 1157, 1086, 1044, 1003, 984, 910, 856, 746, 732,
665 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 7.0 Hz, 1H),
7.83 (d, J = 7.5 Hz, 1H), 7.68 (s, 1H), 7.50 (s, 1H) 7.33−7.29 (m,
1H), 7.27−7.23 (m, 1H), 3.80 (s, 3H), 3.73 (d, J = 12.1 Hz, 3H), 3.59
(dd, J = 15.3, 1.2 Hz, 2H), 3.49−3.44 (m, 1H) 3.19−3.12 (m, 1H)
2.87−2.76 (m, 2H) 2.14−2.04 (m, 1H), 1.98−1.87 (m, 1H) 1.66 (s,
9H); 13C NMR (100 MHz, CDCl3): δ 175.4, 169.6, 162.8, 152.8,
149.8, 138.2, 135.1, 131.7, 124.9, 124.1, 122.3, 120.0, 116.1, 115.0,
83.4, 74.0, 69.4, 56.3, 51.8, 43.0, 28.2, 26.7, 25.6, 25.4; exact mass calcd
for C26H29N3O6 [M + Na]
+ 502.1949, found 502.1944.
Spectroscopic data reported for α,β-unsaturated methyl ester 23:
mp 94.0−95.0 °C; TLC (40% EtOAc in hexanes) Rf 0.28 (CAM/UV);
IR (film) 2980, 2949, 2882, 1722, 1690, 1640, 1607, 1451, 1370, 1339,
1304, 1256, 1221, 1155, 1080, 1017, 995, 978, 930, 907, 856, 835, 764,
739, 619 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.06 (s, 1H), 7.81
(dd, J = 7.1, 1.3 Hz, 1H), 7.62 (s, 1H), 7.28- 7.20 (m, 2H), 7.13 (s,
1H), 4.07 (dd, J = 15.6, 0.8 Hz, 1H), 3.79 (s, 3H), 3.64 (dd, J = 15.6,
0.8 Hz, 1H), 3.40 (s, 3H), 3.40−3.35 (m, 1H), 3.25−3.19 (m, 1H),
2.74 (m, 1H), 2.25−2.18 (m, 1H), 2.10−2.00 (m, 2H), 1.63 (s, 9H);
13C NMR (100 MHz, CDCl3): δ 174.4, 169.7, 164.6, 150.0, 147.5,
144.4, 135.1, 132.3, 124.5, 124.0, 122.1, 120.7, 117.6, 114.9, 83.1, 75.7,
67.6, 56.3, 52.1, 42.7, 28.4, 26.8, 25.5, 25.3; exact mass calcd for
C26H29N3O6 [M + Na]
+ 502.1949, found 502.1944.
Methyl (6S*,7S*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-
3-yl)methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-7-carboxylate (24) and Methyl
(6S*,7R*,8aS*)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-yl)-
methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-7-carboxylate (25). Unsaturated ester
23 (182 mg, 0.378 mmol) was dissolved in MeOH (4 mL) at rt, and
10% Pd/C (25 mg) was added. One balloon of H2 gas was used to
sparge the reaction mixture (10 min); a second balloon was
maintained above the reaction mixture during the course of the
reaction to provide an atmosphere of H2. When TLC indicated
consumption of starting material (1 h), the reaction mixture was
filtered through Celite, and the filter pad was washed with MeOH.
After removal of the solvent in vacuo, a white powder was obtained
that contained an equal mixture of diastereomers as judged by 1H
NMR on the unpurified reaction mixture. The mixture was purified by
flash chromatography on silica gel (20% to 100% EtOAc in hexanes)
to afford 24 (77 mg, 43% yield) and 25 (78 mg, 43% yield), both
obtained as a colorless amorphous solids. Spectroscopic data for 24:
TLC (60% EtOAC in hexanes) Rf 0.36 (CAM/UV); IR (film) 2980,
2948, 2883, 1732, 1730, 1695, 1687, 1641, 1476, 1457, 1452, 1416,
1371, 1360, 1308, 1257, 1213, 1185, 1161, 1084, 1016, 913, 857, 768,
745, 701, 672 cm−1; 1H NMR (400 MHz, CDCl3): δ 8.07 (d, J = 5.8
Hz, 1H), 7.76 (s, 1H), 7.74 (d, J = 2.0 Hz, 1H), 7.24−7.19 (m, 2H),
3.78 (s, 3H), 3.54 (d, J = 14.8 Hz, 1H), 3.47 (s, 3H), 3.44−3.31 (m,
2H), 3.22 (d, J = 14.9 Hz, 1H), 3.06 (q, J = 4.7 Hz, 1H), 2.65−2.58
(m, 1H), 2.09−1.87 (m, 5H), 1.63 (s, 9H); 13C NMR (100 MHz,
CDCl3): δ 172.4, 171.0, 169.9, 149.9, 134.9, 132.3, 125.7, 123.6, 121.9,
120.3, 116.7, 114.8, 82.8, 69.3, 64.1, 54.7, 51.8, 45.8, 43.4, 37.3, 28.6,
28.2, 27.5, 24.4; exact mass calcd for C26H31N3O6Na [M + Na]
+
504.2105, found 504.2102.
Spectroscopic data for 25: TLC (60% EtOAC in hexanes) Rf 0.43,
(CAM/UV); IR (film) 2979, 2948, 2881, 1731, 1693, 1690, 1689,
1452, 1437, 1419, 1370, 1343, 1301, 1258, 1218, 1162, 1120, 1084,
1045, 1013, 990, 856, 767, 747, 666 cm−1; 1H NMR (400 MHz,
CDCl3): δ 8.09 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.68 (s, 1H), 7.25 (t,
J = 6.2 Hz, 1H), 7.19 (t, J = 7.8 Hz, 1H), 3.75 (s, 1H), 3.71 (s, 3H),
3.68 (s, 3H), 3.29 (d, J = 15.3 Hz, 1H), 2.76 (q, J = 5.1 Hz, 1H), 2.60−
2.54 (m, 1H), 2.08−1.83 (m, 5H), 1.66 (s, 9H); 13C NMR (100 MHz,
CDCl3): δ 172.9, 172.4, 169.8, 149.9, 135.2, 132.3, 125.5, 123.8, 121.8,
121.1, 116.5, 114.8, 83.1, 68.9, 63.3, 54.7, 52.1, 45.2, 43.5, 36.3, 28.7,
28.2, 27.2, 24.6; exact mass calcd for C26H31N3O6Na [M + Na]
+
504.2105, found 504.2102.
tert-Butyl 3-(((6S*,7S*,8aS*)-7-(2-Hydroxypropan-2-yl)-9-
methoxy-5-oxo-2,3,7,8-tetrahydro-1H-6,8a-(azenometheno)-
indolizin-6(5H)-yl)methyl)-1H-indole-1-carboxylate (26). A
flame-dried flask was charged with 24 (12.5 mg, 0.026 mmol) and
flushed with N2 gas for 10 min, dissolved in toluene (0.52 mL), and
cooled to 0 °C. To this solution was added MeMgBr (74 μL, 0.104
mmol, 1.4 M in THF). The reaction was stirred for 1 h at 0 °C, diluted
with NH4Cl (10 mL), and extracted with EtOAc (3 × 10 mL). The
combined organic layers were washed with saturated NaCl (40 mL),
dried (Na2SO4), filtered, and concentrated in vacuo. The resulting
product was purified by flash chromatography on silica gel (50% →
100% EtOAc in hexanes) to afford the derived lactim tertiary alcohol
26 as a white foam (7.4 mg, 59% yield): TLC (80% EtOAc in hexanes)
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Rf 0.35 (CAM/UV); IR (film) 3406, 2976, 2945, 2880, 1726, 1661,
1451, 1424, 1368, 1354, 1256, 1207, 1155, 1103, 1080, 1011, 955, 924,
924, 856, 820, 743 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.05 (br s,
1H), 7.84−7.82 (m, 1H), 7.69 (s, 1H), 7.24−7.18 (m, 2H), 3.75 (d, J
= 14.8 Hz, 1H), 3.69 (s, 3H), 3.51 (d, J = 14.9 Hz, 1H), 3.47−3.41 (m,
1H), 3.28−3.22 (m, 1H), 2.50 (dt, J = 12.9, 7.4 Hz, 1H), 2.35 (dd, J =
9.8, 6.2 Hz, 1H), 2.04 (dd, J = 12.9, 9.8, 1H), 1.97−1.82 (m, 3H), 1.76
(br s, 1H), 1.63 (s, 9H), 1.41 (dd, J = 12.9, 6.2 Hz, 1H), 1.32 (s, 3H),
1.22 (s, 3H); 13C (100 MHz, CDCl3) δ 171.5, 169.8, 150.0, 134.8,
132.6, 125.5, 123.3, 121.7, 120.7, 118.8, 114.7, 82.7, 74.2, 71.7, 63.4,
54.1, 51.9, 43.2, 37.9, 31.2, 28.6, 28.2, 25.9, 24.2; exact mass calcd for
C27H35N3O5Na [M + Na]
+ 504.2469, found 504.2468.
tert-Butyl 3-(((6S,7S,8aS)-7-(2-Hydroxypropan-2-yl)-5,9-diox-
otetrahydro-1H-6,8a-(epiminomethano)indolizin-6(5H)-yl)-
methyl)-1H-indole-1-carboxylate (27). A reaction flask was
charged with lactim tertiary alcohol 26 (15.8 mg, 0.033 mmol) and
flushed with N2 gas for 10 min, dissolved in CH2Cl2 (3.5 mL), and
cooled to 0 °C. To the reaction flask was added p-TsOH·H2O (7.3 mg,
0.038 mmol). The reaction was stirred and slowly warmed to ambient
temperature over 6 h. The reaction mixture was diluted with satd aq
NaHCO3 (10 mL), and extracted with EtOAc (4 × 10 mL). The
combined organic layers were washed with saturated NaCl (40 mL),
dried (Na2SO4), filtered, and concentrated in vacuo. The resulting
product (which contained some amino methyl ester) was dissolved in
toluene (3 mL) and stirred at 110 °C for 18 h. The solution was
concentrated in vacuo to obtain lactam tertiary alcohol 27 (15.5 mg,
95% yield) which was used without further purification: TLC (80%
EtOAc in hexanes) Rf 0.32 (CAM/UV); IR (film) 3393, 2928, 1688,
1682, 1674, 1451, 1367, 1339, 1310, 1258, 1221, 1153, 1085, 1022,
961, 934, 856, 802, 745, 694, 665, 592 cm−1; 1H NMR (400 MHz,
CDCl3) δ 8.12 (d, J = 7.4 Hz, 1H), 7.64 (s, 1H), 7.60 (d, J = 7.1 Hz,
1H), 7.33−7.16 (m, 2H), 5.70 (br s, 1H), 4.01 (d, J = 15.6 Hz, 1H),
3.64−3.52 (m, 2H), 3.40 (dt, J = 11.8, 6.6 Hz, 1H), 2.65 (dt, J = 12.9,
7.4 Hz, 1H), 2.36 (s, 1H), 2.31 (dd, J = 10.2, 6.6 Hz, 1H), 2.13 (dd, J
= 13.3, 10.2 Hz, 1H), 1.97 (apparent quint, J = 7.0 Hz, 2H), 1.82−1.74
(m, 2H), 1.66 (s, 9H), 1.45 (s, 3H), 1.30 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 172.4, 169.3, 149.6, 135.1, 131.5, 126.8, 124.5, 122.9,
118.0, 115.5, 114.6, 83.7, 73.8, 66.8, 65.8, 50.7, 44.2, 36.2, 32.0, 28.2,
24.1, 23.7, 23.5; exact mass calcd for C26H33N3O5Na [M + Na]
+
490.2312, found 490.2312.
12,12-Dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-
5a,13a-(epiminomethano)indolizino[7,6-b]carbazole-5,14-
dione (2). A reaction flask was charged with lactam tertiary alcohol 27
(11.5 mg, 0.025 mmol), fitted with a reflux condenser, and flushed
with N2 gas for 10 min. PhMe (3.7 mL) and p-TsOH·H2O (4.7 mg,
0.025 mmol) were added, and the reaction vessel was heated to 100
°C for 6 h. After being cooled to rt, the reaction was diluted with satd
aqueous NaHCO3 (10 mL) and extracted with EtOAc (3 × 10 mL).
The combined organic layers were washed with saturated NaCl (40
mL), dried (Na2SO4), filtered, and concentrated in vacuo to obtain 2
as a white powder (7.1 mg, 83% yield). The material thus obtained was
>95% pure as judged by 1H NMR and further purification was not
performed: TLC (100% EtOAc) Rf 0.45 (CAM/UV); IR (film) 3325,
3310, 3233, 3221, 3210, 2990, 2947, 2901, 1656, 1670, 1451, 1404,
1369, 1339, 1300, 1258, 1196, 1161, 1092, 1011, 922, 860, 802, 772,
748, 718, 698, 644, 594; 1H NMR (400 MHz, CDCl3) δ 7.89 (br s,
1H), 7.52 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H), 7.18 (td, J =
7.5, 1.3 Hz, 1H), 7.12 (td, J = 7.5, 1.2 Hz, 1H), 5.88 (br s, 1H), 3.93
(d, J = 18 Hz, 1H), 3.54 (t, J = 6.9 Hz, 2H), 2.91 (d, J = 18 Hz, 1H),
2.81 (quint, J = 6.7 Hz, 1H), 2.34 (dd, J = 9.8, 4.3 Hz, 1H), 2.18−1.99
(m, 4H), 1.89−1.82 (m, 1H), 1.33 (s, 3H), 1.28 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 172.7, 169.0, 139.6, 136.4, 127.2, 122.1, 119.7,
118.3, 110.7, 103.6, 67.1, 61.6, 45.7, 44.2, 34.5, 32.6, 29.1, 29.0, 25.3,
24.5, 23.9. exact mass calcd for spray dimer C42H46N6O4Na [M + M +
Na]+ 721.3473, found 721.3476. The spectral data for 2 were identical
with an authentic sample provided by Williams (Colorado State
University).
Methyl (6S,7R,8aS)-6-((1-(tert-Butoxycarbonyl)-1H-indol-3-
yl)methyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)-
indolizine-7-carboxylate (28). A reaction flask was charged with
lactim methyl ester 25 (48 mg, 0.099 mmol) and flushed with N2 gas
for 10 min, dissolved in CH2Cl2 (10 mL), and cooled to 0 °C. To the
reaction flask was added pTsOH·H2O (24 mg, 0.13 mmol), and the
reaction was stirred for 6 h while slowly warming to rt. The reaction
mixture was diluted with satd aq NaHCO3 (10 mL) and extracted with
EtOAc (4 × 10 mL). The combined organic layers were washed with
saturated NaCl (40 mL), dried (Na2SO4), filtered, and concentrated in
vacuo. The resulting product (which contained some amino methyl
ester) was dissolved in toluene (10 mL) and stirred at 110 °C for 18 h.
The solution was concentrated in vacuo to obtain the lactam 28 as a
white powder (15.7 mg, 88% yield). The material thus obtained was
>95% pure as judged by 1H NMR, and further purification was not
performed: TLC (70% EtOAc in hexanes) Rf 0.30 (CAM/UV); IR
(film) 3175, 3117, 3082, 3051, 2978, 2936, 2882, 1736, 1724, 1690,
1450, 1385, 1362, 1312, 1254, 1196, 1153, 1092, 1308, 1018, 964, 934,
922, 899, 849, 837, 768, 745, 691, 563; 1H NMR (400 MHz, CDCl3) δ
8.15 (d, J = 8.2 Hz, 1H), 7.71 (s, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.36
(td, J = 7.6, 1.2 Hz, 1H), 7.29 (td, J = 7.6, 1.2 Hz, 1H), 5.75 (br s, 1H),
3.82 (s, 3H), 3.66−3.53 (m, 3H), 3.30 (dd, J = 9.8, 4.7 Hz, 1H), 3.19
(d, J = 15.6 Hz, 1H), 2.73−2.66 (m, 1H), 2.28- − 2.15 (m, 2H), 2.10−
1.98 (m, 2H), 1.85−1.79 (m, 1H), 1.69 (s, 9H); 13C NMR (100 MHz,
CDCl3) δ 172.3, 171.6, 166.4, 149.4, 135.4, 130.8, 126.2, 125.0, 123.3,
118.1, 115.7, 112.4, 84.1, 66.1, 63.4, 52.7, 48.2, 44.3, 34.8, 28.9, 28.2,
24.3, 24.0.exact mass calcd for C25H29N3O6Na [M + Na]
+ 490.1949,
found 490.1948. Spectral data agrees with that reported by Baran.24
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